UCB
The Medical Strategy Lead will lead United States medical strategy and execution for an emerging regenerative neural cell therapy, translating global strategy into launch-readiness and field-medical plans. This senior medical leader will enable compliant scientific exchange, represent regional perspectives globally, and build credible relationships across priority healthcare ecosystems. The role involves partnering with global and cross-functional teams to guide field medical colleagues and engage external scientific experts and stakeholders.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
MSL Field Medical Director, Oncology (Remote)
AbbVie
Director, Field Medical – Movement Disorders
ExecuSearch of Chicago
Senior Medical Science Liaison, Lymphoma (Lacutamab)
Sobi
Global Medical Lead, Neurometabolic
ITF Therapeutics
Senior Director, Global Medical Affairs
Centessa Pharmaceuticals
Executive Director, Center for Scientific Exchange Excellence (ED CSEE)
Merck & Co., Inc.